Suppr超能文献

阿尔茨海默病外周细胞外囊泡的生物标志物和治疗潜力。

Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer's disease.

机构信息

VIB Center for Inflammation Research, VIB, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.

Intramural Research Program, Laboratory of Clinical Investigation, National Institute on Aging, Baltimore, USA; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, USA.

出版信息

Adv Drug Deliv Rev. 2022 Nov;190:114486. doi: 10.1016/j.addr.2022.114486. Epub 2022 Aug 8.

Abstract

Extracellular vesicles (EVs) are cell-derived nanoparticles with an important role in intercellular communication, even across brain barriers. The bidirectional brain-barrier crossing capacity of EVs is supported by research identifying neuronal markers in peripheral EVs, as well as the brain delivery of peripherally administered EVs. In addition, EVs are reflective of their cellular origin, underlining their biomarker and therapeutic potential when released by diseased and regenerative cells, respectively. Both characteristics are of interest in Alzheimer's disease (AD) where the current biomarker profile is solely based on brain-centered readouts and effective therapeutic options are lacking. In this review, we elaborate on the role of peripheral EVs in AD. We focus on bulk EVs and specific EV subpopulations including bacterial EVs (bEVs) and neuronal-derived EVs (nEVs), which have mainly been studied from a biomarker perspective. Furthermore, we highlight the therapeutic potential of peripherally administered EVs whereby research has centered around stem cell derived EVs.

摘要

细胞外囊泡(EVs)是细胞来源的纳米颗粒,在细胞间通讯中具有重要作用,甚至可以跨越血脑屏障。EVs 具有双向穿越血脑屏障的能力,这一能力得到了研究的支持,研究发现外周 EV 中存在神经元标志物,以及外周给予的 EV 可向脑内递送。此外,EVs 反映了其细胞起源,当病变细胞和再生细胞分别释放 EV 时,凸显了它们作为生物标志物和治疗潜力。这两个特征都与阿尔茨海默病(AD)有关,目前的生物标志物谱仅基于以大脑为中心的检测结果,缺乏有效的治疗选择。在这篇综述中,我们详细阐述了外周 EV 在 AD 中的作用。我们重点介绍了批量 EV 以及特定的 EV 亚群,包括细菌 EV(bEVs)和神经元衍生的 EV(nEVs),这些亚群主要从生物标志物的角度进行了研究。此外,我们还强调了外周给予 EV 的治疗潜力,研究主要集中在干细胞衍生的 EV 上。

相似文献

1
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer's disease.
Adv Drug Deliv Rev. 2022 Nov;190:114486. doi: 10.1016/j.addr.2022.114486. Epub 2022 Aug 8.
3
Mesenchymal stem cell-derived extracellular vesicles: A novel promising neuroprotective agent for Alzheimer's disease.
Biochem Pharmacol. 2024 Apr;222:116064. doi: 10.1016/j.bcp.2024.116064. Epub 2024 Feb 17.
5
Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
J Neurovirol. 2019 Oct;25(5):702-709. doi: 10.1007/s13365-018-0695-4. Epub 2019 Jan 4.
7
Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study.
J Proteomics. 2024 Sep 30;308:105279. doi: 10.1016/j.jprot.2024.105279. Epub 2024 Aug 17.
10
Extracellular Vesicles of Alzheimer's Disease Patients as a Biomarker for Disease Progression.
Mol Neurobiol. 2020 Oct;57(10):4156-4169. doi: 10.1007/s12035-020-02013-1. Epub 2020 Jul 17.

引用本文的文献

3
Extracellular vesicles: new horizons in neurodegeneration.
EBioMedicine. 2025 Mar;113:105605. doi: 10.1016/j.ebiom.2025.105605. Epub 2025 Mar 3.
4
The Role of Extracellular Vesicles in Aging and Age-Related Disorders.
Antioxidants (Basel). 2025 Feb 3;14(2):177. doi: 10.3390/antiox14020177.
5
Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review.
ACS Omega. 2025 Feb 3;10(6):5148-5171. doi: 10.1021/acsomega.4c05527. eCollection 2025 Feb 18.
6
Extracellular Vesicles: A Promising Therapeutic Approach to Alzheimer's Disease.
Curr Alzheimer Res. 2024;21(9):615-624. doi: 10.2174/0115672050365314250112042136.
7
Filter-Aided Extracellular Vesicle Enrichment (FAEVEr) for Proteomics.
Mol Cell Proteomics. 2025 Feb;24(2):100907. doi: 10.1016/j.mcpro.2025.100907. Epub 2025 Jan 21.
8
Biomarkers of mature neuronal differentiation and related diseases.
Future Sci OA. 2024 Dec 31;10(1):2410146. doi: 10.1080/20565623.2024.2410146. Epub 2024 Oct 21.
9
Alzheimer's disease biomarkers and their current use in clinical research and practice.
Mol Psychiatry. 2025 Jan;30(1):272-284. doi: 10.1038/s41380-024-02709-z. Epub 2024 Sep 4.
10

本文引用的文献

1
Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease.
Brain. 2023 Jan 5;146(1):195-208. doi: 10.1093/brain/awac258.
2
Identification of storage conditions stabilizing extracellular vesicles preparations.
J Extracell Vesicles. 2022 Jun;11(6):e12238. doi: 10.1002/jev2.12238.
3
The tremendous biomedical potential of bacterial extracellular vesicles.
Trends Biotechnol. 2022 Oct;40(10):1173-1194. doi: 10.1016/j.tibtech.2022.03.005. Epub 2022 May 14.
5
Challenges and directions in studying cell-cell communication by extracellular vesicles.
Nat Rev Mol Cell Biol. 2022 May;23(5):369-382. doi: 10.1038/s41580-022-00460-3. Epub 2022 Mar 8.
6
Alzheimer's disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus.
EBioMedicine. 2022 Mar;77:103903. doi: 10.1016/j.ebiom.2022.103903. Epub 2022 Feb 25.
7
Novel Exosome Biomarker Candidates for Alzheimer's Disease Unravelled Through Mass Spectrometry Analysis.
Mol Neurobiol. 2022 May;59(5):2838-2854. doi: 10.1007/s12035-022-02762-1. Epub 2022 Feb 25.
8
Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer's Disease.
Cells. 2022 Jan 27;11(3):436. doi: 10.3390/cells11030436.
9
Fighting fire with fire: The immune system might be key in our fight against Alzheimer's disease.
Drug Discov Today. 2022 May;27(5):1261-1283. doi: 10.1016/j.drudis.2022.01.004. Epub 2022 Jan 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验